Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.24B |
| 2 |
Apple
AAPL
|
+$939M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$714M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$673M |
| 5 |
Alibaba
BABA
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.45B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$653M |
| 3 |
GE Aerospace
GE
|
+$501M |
| 4 |
S&P Global
SPGI
|
+$439M |
| 5 |
SPDR Gold Trust
GLD
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.97% |
| 2 | Financials | 10.16% |
| 3 | Consumer Discretionary | 8.05% |
| 4 | Healthcare | 7.74% |
| 5 | Communication Services | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.19B
| $3.17M | ﹤0.01% |
110,975
+8,313
| +8% | +$234K |
|
3527
Arbutus Biopharma
ABUS
$921M
| $3.17M | ﹤0.01% |
628,677
+207,076
| +49% | +$1.21M |
|
3528
Fate Therapeutics
FATE
$318M
| $3.17M | ﹤0.01% |
519,062
-62,175
| -11% | -$277K |
|
|
PCN
3529
PIMCO Corporate & Income Strategy Fund
PCN
$888M
| $3.17M | ﹤0.01% |
184,375
-13,152
| -7% | -$223K |
|
|
NUO
3530
DELISTED
Nuveen Ohio Quality Municipal Income Fund
NUO
| $3.17M | ﹤0.01% |
216,520
+1,056
| +0.5% | +$15.7K |
|
3531
Financial Institutions
FISI
$818M
| $3.17M | ﹤0.01% |
101,874
-7,376
| -7% | -$232K |
|
3532
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$83.4M
| $3.17M | ﹤0.01% |
48,641
-679
| -1% | -$42.7K |
|
|
UMH
3533
UMH Properties
UMH
$1.38B
| $3.16M | ﹤0.01% |
212,365
-15,132
| -7% | -$230K |
|
|
SVU
3534
DELISTED
SUPERVALU Inc.
SVU
| $3.16M | ﹤0.01% |
146,534
+28,253
| +24% | +$516K |
|
3535
Brown-Forman Class A
BF.A
$13B
| $3.16M | ﹤0.01% |
58,771
+31,261
| +114% | +$1.5M |
|
|
BEL
3536
DELISTED
Belmond Ltd.
BEL
| $3.16M | ﹤0.01% |
258,022
+134,986
| +110% | +$1.73M |
|
3537
WhiteHorse Finance
WHF
$150M
| $3.16M | ﹤0.01% |
235,451
+15,181
| +7% | +$215K |
|
3538
iShares 1-3 Year International Treasury Bond ETF
ISHG
$826M
| $3.16M | ﹤0.01% |
37,515
+10,662
| +40% | +$890K |
|
3539
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$394M
| $3.15M | ﹤0.01% |
54,080
+3,822
| +8% | +$220K |
|
|
GES
3540
DELISTED
Guess Inc
GES
| $3.15M | ﹤0.01% |
186,812
+53,002
| +40% | +$878K |
|
|
SHYF
3541
DELISTED
The Shyft Group
SHYF
| $3.15M | ﹤0.01% |
200,278
+82,620
| +70% | +$1.26M |
|
3542
BlackLine
BL
$1.65B
| $3.15M | ﹤0.01% |
96,127
+51,769
| +117% | +$1.81M |
|
3543
Alkermes
ALKS
$8.35B
| $3.15M | ﹤0.01% |
57,581
-11,582
| -17% | -$591K |
|
3544
Agree Realty
ADC
$9.18B
| $3.15M | ﹤0.01% |
61,201
-1,969
| -3% | -$97.6K |
|
|
DMC
3545
Del Monte Corp
DMC
$1.43B
| $3.15M | ﹤0.01% |
65,999
-196,669
| -75% | -$9.26M |
|
|
CRCM
3546
DELISTED
CARE.COM, INC.
CRCM
| $3.15M | ﹤0.01% |
174,352
+12,425
| +8% | +$217K |
|
3547
State Street SPDR S&P Health Care Services ETF
XHS
$210M
| $3.14M | ﹤0.01% |
51,044
-21,275
| -29% | -$1.26M |
|
3548
Monarch Casino & Resort
MCRI
$2.2B
| $3.14M | ﹤0.01% |
70,055
+24,549
| +54% | +$1.09M |
|
3549
ProShares Ultra S&P500
SSO
$8.4B
| $3.14M | ﹤0.01% |
229,416
+118,216
| +106% | +$1.53M |
|
3550
Agios Pharmaceuticals
AGIO
$1.94B
| $3.13M | ﹤0.01% |
54,839
-48,073
| -47% | -$3.02M |
|
Similar funds
Morgan Stanley's Q4 2017 Portfolio in Review
As of Q4 2017, Morgan Stanley held 6,934 positions worth $365B, up 9.4% from $334B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $13.3B of net new capital in Q4 2017, opening 268 new positions and adding to 3,628 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 7,527,774 shares worth $117M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $1.45B trimmed.
- Morgan Stanley's largest Q4 2017 buy was Highland Opportunities and Income Fund: 7,527,774 shares worth $117M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $4.24B increase.
- Morgan Stanley's biggest Q4 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.45B.
- Morgan Stanley fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $210M.
- Morgan Stanley's ten largest holdings make up 14% of its $365B portfolio in Q4 2017.
- Morgan Stanley opened 268 new positions and closed 177 in Q4 2017.
- Morgan Stanley's portfolio value rose 9.4% quarter-over-quarter to $365B.
Based on Morgan Stanley's 13F filing for Q4 2017, filed 14 Feb 2018.